Hi Tiny,
I find it hard to believe they are still sitting there.
Cap raise I cant see it.
SI could license out Crohns instead of raising Capital or just
use the debt facility.
Cash spend is reducing and Japan is adding to the balance sheet.
Also as soon as a product is approved Big Pharma make an offer to good to
refuse.?? Some reason we are at all time lows with all time possibilities.??
Aloha.
MSB Trading 2022, The TurnAround, page-494
-
- There are more pages in this discussion • 555 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
-0.025(2.17%) |
Mkt cap ! $1.284B | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.16 | $1.11 | $7.363M | 6.488M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 94863 | $1.13 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 5000 | 2 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |